| |
|
|
|
NovaBay Pharmaceuticals- Inc.  
|
|
2.15 0.018 (0.01%) |
08-14 13:20 |
|
Open: |
2.15 |
Pre close: |
2.1319 |
Target:
|
2.75
|
|
High: |
2.15 |
Low: |
2.112 |
Resistance:
|
2.35
2.55
|
|
Volume: |
3,089 |
Market Cap: |
37M |
Support:
|
2.03
1.69
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.17
 |
MACD |
MACD(12,26):
|
-0.07 |
|
MA(20): |
2.31 |
Signal(12,26,9): |
-0.05 |
|
MA(100): |
2.74 |
Stochastic Oscillator |
%K(14,3):
|
24.48 |
|
MA(250): |
3.49 |
%D(3): |
27.22 |
|
Average Volume(K) |
3-Month: |
1158
|
52-Week |
High:
|
4.80 |
|
10-Days: |
393 |
Low: |
2.00 |
|
RSI |
RSI(14):
|
39.15  |
Change(%): |
-52.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.430 |
Return on Equity (ttm) |
-101.4 |
Shares Out. (M) |
17.09 |
|
EPS Est. Current Year |
-0.470 |
Return on Assets (ttm) |
-45.4 |
Shares Float (M) |
15.31 |
|
EPS Est. Next Year |
-0.090 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.40 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
-20.4 |
% Held by Institutions |
10.70 |
|
Forward EPS |
-0.170 |
Gross Profit (p.s.) |
0.209 |
Shares Short (K) |
127 |
|
Book Value (p.s.) |
5.050 |
EBITDA (p.s.) |
-0.126 |
P/E |
-5.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.43 |
|
Profit Margin |
-33.57 |
Operating Cash Flow
(M) |
-4.73 |
P/S |
32806696.00 |
|
Operating Margin |
-33.77 |
Levered Free Cash Flow
(M) |
-3.56 |
P/CF |
-7.77 |
|
|
|
|
|
|
